Literature DB >> 13150213

Rheumatoid arthritis; an evaluation of long-term treatment with cortisone.

E P ENGLEMAN, M A KRUPP, W W SAUNDERS, L E WILSON, E W FREDELL.   

Abstract

Fifty-six patients with rheumatoid arthritis were treated continuously with cortisone for periods ranging between 4 and 38 months, in daily doses of 15 to 100 mg. Concomitant therapy included periods of rest, physical therapy, and salicylates. The incidence of subjective improvement exceeded that of objective improvement. The incidence of objective improvement was higher in females; also, in those patients whose disease was in an early stage and of short duration at the time therapy was begun, and who required relatively smaller maintenance doses of cortisone. Therapeutic results were not affected by the age of the patient or by the presence of spondylitis. Despite precautions, the long-term administration of cortisone was, in some patients, productive of serious undesirable side-effects. Although cortisone usually suppressed the symptoms and signs of rheumatoid arthritis, progression of the disease was frequently noted during its long-term administration.

Entities:  

Keywords:  ARTHRITIS, RHEUMATOID/therapy; CORTISONE/therapeutic use

Mesh:

Substances:

Year:  1954        PMID: 13150213      PMCID: PMC1531762     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  10 in total

1.  Rheumatic complaints during chronic hypercortisonism and syndromes during withdrawal of cortisone in rheumatic patients.

Authors:  C H SLOCUMB
Journal:  Proc Staff Meet Mayo Clin       Date:  1953-11-18

2.  Observations on the use of cortisone and ACTH in rheumatoid arthritis.

Authors:  W S CLARK; H O TONNING; J P KULKA; W BAUER
Journal:  N Engl J Med       Date:  1953-10-15       Impact factor: 91.245

3.  The prolonged treatment of rheumatoid arthritis with cortisone and corticotropin.

Authors:  M H LEVIN; J B RIVO; W SCOTT; W G FIGUEROA; L FRED; T F BARRETT
Journal:  Am J Med       Date:  1953-03       Impact factor: 4.965

4.  Rheumatism and arthritis: review of American and English literature of recent years. (Tenth Rheumatism Review). I.

Authors:  W D ROBINSON; E W BOLAND; J J BUNIM; D C CRAIN; E P ENGLEMAN; W GRAHAM; L M LOCKIE; M M MONTGOMERY; C RAGAN; M W ROPES; E F ROSENBERG; C J SMYTH
Journal:  Ann Intern Med       Date:  1953-09       Impact factor: 25.391

5.  Adrenocortical function during continuous longterm therapy with cortisone.

Authors:  E P ENGLEMAN; M A KRUPP; H P JOHNSON; J E WELSH; H T WRENN; W R KING
Journal:  AMA Arch Intern Med       Date:  1953-01

6.  The reversibility of certain rheumatic and nonrheumatic conditions by the use of cortisone or of the pituitary adrenocotropic hormone.

Authors:  P S HENCH
Journal:  Ann Intern Med       Date:  1952-01       Impact factor: 25.391

7.  Management of rheumatoid arthritis with smaller (maintenance) doses of cortisone acetate.

Authors:  E W BOLAND; N E HEADLEY
Journal:  J Am Med Assoc       Date:  1950-09-30

8.  Effect of cortisone and pituitary adrenocorticotropic hormone (ACTH) on rheumatic diseases.

Authors:  P S HENCH; C H SLOCUMB; H F POLLEY; E C KENDAL
Journal:  J Am Med Assoc       Date:  1950-12-16

9.  Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions.

Authors:  P S HENCH; E C KENDALL; C H SLOCUMB; H F POLLEY
Journal:  Arch Intern Med (Chic)       Date:  1950-04

10.  Experiences with cortisone given orally.

Authors:  E P ENGLEMAN; P KUNKEL; J E WELSH; M G MOLYNEAUX
Journal:  Calif Med       Date:  1951-07
  10 in total
  1 in total

1.  Recent advances in rheumatic diseases.

Authors:  E W BOLAND
Journal:  Calif Med       Date:  1955-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.